SonoScape obtains CE Mark for its linear array echoendoscope EG-UC5T
PR90436
SHENZHEN, China, July 2, 2021 /PRNewswire=KYODO JBN/ --
On April 30th, SonoScape received the CE-marking, the product's "Passport to
Europe", for its linear-array echoendoscope EG-UC5T. This further expands
SonoScape's endoscopic ultrasound (EUS) portfolio in the international market.
Reaping the benefits of decades of ultrasound technology know-how, SonoScape's
EUS product line officially debuted in September 2019, when its 360°
radial-array echoendoscope EG-UR5 obtained the CE Marking, leaping to the 4th
company in the world to master the core technology of EUS.
EG-UC5T is characterised by its large, 4.0-mm instrument channel and its short
rigid distal end, pushing the boundaries of therapeutic excellence. With the
arrival of the linear-array echoendoscope EG-UC5T, SonoScape users are not only
able to perform the adequate tissue sampling, but also various therapeutic
interventional endoscopic procedures under the sonographic guidance. This is a
true "best of the two worlds", a golden key to reveal what's behind the GI
tract mucosa and to unlock the growing possibilities of advanced endoscopy.
"SonoScape's EUS portfolio will certainly extend the company's path into more
and larger hospitals. This again underpins the company's leading role in the
global digestive endoscopy market." said Steven He, Sales Director of Endoscopy
Division at SonoScape: "We have achieved great results with our current
gastrointestinal endoscopes, and I am confident that the new linear-array
echoendoscopes will set us to a higher success."
The last 25 years have witnessed a major expansion of EUS to various
applications, both diagnostic and therapeutic, as noted in Friedberg SR,
Lachter J, World Journal of Gastrointestinal Endoscopy (2017). Focused on
delivering high quality products, SonoScape continues to bring significant
value to the world of endoscopy.
About SonoScape
Founded in 2002 in Shenzhen, China, SonoScape has committed itself to "Caring
for life through innovation" by providing ultrasound and endoscopy solutions
and delivering first-rate services. It now has seven R&D centers in Shenzhen,
Shanghai, Harbin, Wuhan, Tokyo, Silicon Valley and Seattle. SonoScape invests
nearly 20% of its revenues into R&D in recent 3 years, with more advanced
products to be introduced into the pipeline.
SOURCE: SonoScape Medical Corporation
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=395273
Caption: CE Marking
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。